0001437749-23-032239.txt : 20231115
0001437749-23-032239.hdr.sgml : 20231115
20231115215518
ACCESSION NUMBER: 0001437749-23-032239
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231113
FILED AS OF DATE: 20231115
DATE AS OF CHANGE: 20231115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Demopulos Gregory A MD
CENTRAL INDEX KEY: 0001472160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34475
FILM NUMBER: 231412294
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVENUE WEST
CITY: SEATTLE
STATE: WA
ZIP: 98119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OMEROS CORP
CENTRAL INDEX KEY: 0001285819
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911663741
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 ELLIOTT AVENUE WEST
CITY: SEATTLE
STATE: WA
ZIP: 98119
BUSINESS PHONE: 206-676-5000
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVENUE WEST
CITY: SEATTLE
STATE: WA
ZIP: 98119
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-11-13
0001285819
OMEROS CORP
OMER
0001472160
Demopulos Gregory A MD
201 ELLIOTT AVENUE WEST
SEATTLE
WA
98119
1
Chairman, CEO & President
0
Common Stock
2023-11-13
4
A
0
37500
1.29
A
83945
I
By Spouse
Common Stock
2023-11-14
4
A
0
25000
1.44
A
108945
I
By Spouse
Common Stock
2026986
D
This transaction was executed in multiple trades at prices ranging from $1.26 to $1.30. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and nothing in this report shall be deemed an admission that the reporting person is the beneficial owner of such securities under Section 16 of the Securities Exchange Act of 1934 or for any other purpose. The shares reported herein include shares held by the reporting person's spouse with respect to which it was previously determined that the reporting person did not have an indirect pecuniary interest.
This transaction was executed in multiple trades at prices ranging from $1.43 to $1.45. The price reported above reflects the weighted average sales price.The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in thisfootnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and nothing in this report shall be deemed an admission that the reporting person is the beneficial owner of such securities under Section 16 of the Securities Exchange Act of 1934 or for any other purpose.
/s/ Peter Cancelmo, Attorney-in-Fact
2023-11-15